Related Experiment Video
Updated: Oct 10, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID-19 pandemic
Cavid Baba1, Pinar Yigit2, Seda Dastan2
1Institute of Health Scienes Dokuz Eylul University Izmir Turkey.
Background:
Coronavirus disease of the 2019 pandemic caused much fear among people with chronic diseases and those on immunosuppressant treatment because of spreading knowledge that the infection has a fatal course in these populations. People with Multiple Sclerosis on ocrelizumab treatment share this fear too. We aimed to investigate treatment and lifestyle changes of people with multiple sclerosis on ocrelizumab treatment during the lockdown.
Methods:
We surveyed 199 of our registered multiple sclerosis patients on ocrelizumab treatment by phone.
Results:
In this survey, delays in treating 22 (11%) patients were not caused by fear of immunosuppressive drug use but rather by the general fear of contracting a fatal disease, which is the case during traveling and hospital visits. There was a positive correlation between living alone and treatment delay (P = .029), emphasizing the role of family support or just the presence of another person during the pandemic.
Conclusion:
Vaccines might soon solve the pandemic's issue, which is not the case with multiple sclerosis progression, so we should think twice before discontinuing the treatment.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Cystic Fibrosis: Management
Sinus disease and chronic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents